Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.26
-0.10 (-1.87%)
At close: Aug 26, 2026, 4:00 PM EDT
5.26
0.00 (0.00%)
After-hours: Aug 26, 2026, 4:20 PM EDT
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $316.15 million as of August 26, 2026. Its market cap has increased by 125.37% in one year.
Market Cap
316.15M
Enterprise Value
276.95M
1-Year Change
125.37%
Ranking
Category
Stock Price
$5.26
ChartMarket Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $316.15M, an increase of 60.12%. That is a compound annual growth rate of 8.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 316.15M | 34.92% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SAB Biotherapeutics | 343.93M |
| Immuneering | 342.90M |
| Opus Genetics | 336.94M |
| ProQR Therapeutics | 330.22M |
| YD Bio | 329.80M |
| Vicore Pharma Holding AB | 327.03M |
| Vanda Pharmaceuticals | 319.24M |
| InflaRx | 309.47M |